To our knowledge, the present study is the first to explore the effect of GABRG2 polymorphism and CSA on cognitive deficit while adjusting for modulating factors in depressed attempters, depressed non-attempters and health controls. The gene discussed is GABRG2; the disease is Cognitive impairment.